Articles

The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangements

University of British Columbia, Dept. of Microbiology and Immunology, MSL Building, 2125 East Mall Vancouver, BC
Terry Fox Laboratory, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC
Terry Fox Laboratory, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC
Terry Fox Laboratory, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC
Ulm University Hospital, Dept of Internal Medicine III, Albert-Einstein-Allee 23, Ulm
Ulm University Hospital, Dept of Internal Medicine III, Albert-Einstein-Allee 23, Ulm
Ulm University Hospital, Dept of Internal Medicine III, Albert-Einstein-Allee 23, Ulm
Ulm University Hospital, Dept of Internal Medicine III, Albert-Einstein-Allee 23, Ulm
Ulm University Hospital, Dept of Internal Medicine III, Albert-Einstein-Allee 23, Ulm
Department of Medicine III, University Hospital, LMU Munich, Marchioninistr. 15, Munich
Department of Pathology, Stanford University School of Medicine, Stanford, CA
Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin
Terry Fox Laboratory, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC
Terry Fox Laboratory, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC
Haematologica Early view Dec 2, 2021 https://doi.org/10.3324/haematol.2021.276048